Development and Validation of a New BAG-1L-Specific Antibody to Quantify BAG-1L Protein Expression in Advanced Prostate Cancer. (2023)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.labinv.2023.100245
PubMed Identifier: 37652207
Publication URI: http://europepmc.org/abstract/MED/37652207
Type: Journal Article/Review
Volume: 103
Parent Publication: Laboratory investigation; a journal of technical methods and pathology
Issue: 11
ISSN: 0023-6837